DSS, Inc. (DSS) shareholders
DSSNYSEPaperboard Containers & BoxesFiscal year ends December 31
$0.53+0.01 (+1.00%)
Close on Nov 13, 2026Market cap $5.27MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
4.3%
0M of 10M shares
Institutional holders
16
4 new, 4 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 1 sales
Net sold $17.92K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Heng Fai Ambrose Chan Joint filing with Alset Inc. (80.00%), Alset International Limited (71.00%) | 26,311,715 | 86.30% | 13D (active) amendment | Sep 3, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of DSS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Hrt Financial LP | 208,481 | 2.08% | $123.00K | New | 0.00% |
| Vanguard Capital Management LLC | 58,032 | 0.58% | $34.24K | – | 0.00% |
| UBS Group AG | 55,558 | 0.55% | $32.78K | +55,077 | 0.00% |
| Geode Capital Management, LLC | 27,892 | 0.28% | $16.46K | −26,459 | 0.00% |
| Renaissance Technologies LLC | 27,048 | 0.27% | $15.96K | −10,194 | 0.00% |
| BlackRock, Inc. | 20,977 | 0.21% | $12.38K | – | 0.00% |
| XTX Topco Ltd | 14,323 | 0.14% | $8.45K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 7,527 | 0.07% | $4.44K | +2,361 | 0.00% |
| Vanguard Fiduciary Trust Co | 6,802 | 0.07% | $4.01K | – | 0.00% |
| Wells Fargo & Company/Mn | 157 | 0.00% | $93 | – | 0.00% |
| FMR LLC | 8 | 0.00% | $5 | New | 0.00% |
| SBI Securities Co., Ltd. | 2 | 0.00% | $1 | – | 0.00% |
| Danske Bank A/S | 2 | 0.00% | $1 | – | 0.00% |
| Union Bancaire Privee, UBP SA | 1 | 0.00% | $0 | – | 0.00% |
| Ronald Blue Trust, Inc. | 1 | 0.00% | $1 | New | 0.00% |
| Center for Financial Planning, Inc. | 1 | 0.00% | $1 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 16 | 0M | 4.3% | 4 / 2 | 2 / 4 | 0M | 0M |
| Q1 2026 | 17 | 0M | 2.2% | 5 / 4 | 1 / 3 | 0M | 0M |
| Q4 2025 | 16 | 0M | 1.6% | 3 / 2 | 2 / 1 | 0M | 0M |
| Q3 2025 | 14 | 0M | 1.5% | 2 / 4 | 2 / 5 | 0M | 0M |
| Q2 2025 | 17 | 0M | 1.6% | 4 / 2 | 3 / 0 | 0M | 0M |
| Q1 2025 | 13 | 0M | 1.6% | 1 / 2 | 3 / 1 | 0M | 0M |
| Q4 2024 | 13 | 0M | 1.2% | 1 / 2 | 4 / 0 | 0M | 0M |
| Q3 2024 | 12 | 0M | 1.7% | 3 / 2 | 4 / 4 | 0M | 0M |
| Q2 2024 | 15 | 0M | 1.8% | 2 / 5 | 5 / 2 | 0M | 0M |
| Q1 2024 | 15 | 0M | 1.6% | 15 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
4 funds held DSS in Q2 2026, 52% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of DSS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 58,032 | 0.58% | $34.24K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 46,271 | 0.46% | $22.21K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 5,454 | 0.05% | $2.62K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 1,202 | 0.01% | $577 | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Heng Fai Ambrose Chan | Director, 10% owner | 2,034,922 | 20.26% | Sep 8, 2026 |
| International Ltd Alset | 10% owner | 102,766,013 | 1023.31% | Jul 9, 2026 |
| Inc. Alset | 10% owner | 19,888,262 | 198.04% | Jul 9, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Heng Fai Ambrose Chan Director, 10% owner | Sep 3, 2026 | Sale | −21,852 | $0.82 | $17.92K | 1,031,944 |
| Heng Fai Ambrose Chan Director, 10% owner | Aug 28, 2025 | Sale | +130,679 | $1.35 | $176.42K | 1,053,796 |
| Heng Fai Ambrose Chan Director, 10% owner | Feb 6, 2025 | Award | +1,000,000 | – | – | 1,002,978 |
| Heng Fai Ambrose Chan Director, 10% owner | Dec 10, 2024 | Buy | +820,597 | $0.97 | $795.98K | 3,961,211 |
| Heng Fai Ambrose Chan Director, 10% owner | Dec 10, 2024 | Buy | +205,149 | $0.97 | $198.99K | 1,184,475 |
| William Wai Leung Wu Director | Dec 29, 2023 | Sale | −150,000 | $0.13 | $19.50K | 0 |
| William Wai Leung Wu Director | Dec 29, 2023 | Sale | −1,020 | $0.13 | $133 | 0 |
| Heng Fai Ambrose Chan Director, 10% owner | Dec 28, 2023 | Buy | +672,173 | $0.15 | $100.83K | 19,586,499 |
| Frank D. Heuszel Chief Executive Officer, Director | Apr 10, 2023 | Award | +1,247,078 | $0.22 | $274.36K | 1,312,776 |
| Heng Fai Ambrose Chan Director, 10% owner | Dec 13, 2022 | Buy | +334,921 | $0.23 | $77.03K | 18,914,326 |
| Heng Fai Ambrose Chan Director, 10% owner | Dec 9, 2022 | Buy | +51,385 | $0.19 | $9.76K | 18,579,405 |
| International Ltd Alset 10% owner | Jul 12, 2022 | Other | +21,366,177 | – | – | 81,399,836 |
| Heng Fai Ambrose Chan Director, 10% owner | Jul 7, 2022 | Buy | +17,570,948 | – | – | 60,033,659 |
| William Wai Leung Wu Director | Jun 17, 2022 | Buy | +5,000 | $0.38 | $1.90K | 151,020 |
| William Wai Leung Wu Director | Jun 16, 2022 | Buy | +5,000 | $0.38 | $1.90K | 146,020 |
| William Wai Leung Wu Director | Jun 10, 2022 | Buy | +27,000 | $0.41 | $11.07K | 140,000 |
| William Wai Leung Wu Director | Jun 9, 2022 | Buy | +72,600 | $0.42 | $30.49K | 113,000 |
| William Wai Leung Wu Director | Jun 8, 2022 | Buy | +23,651 | $0.41 | $9.70K | 40,400 |
| William Wai Leung Wu Director | Jun 7, 2022 | Buy | +16,749 | $0.39 | $6.53K | 16,749 |
| Heng Fai Ambrose Chan Director, 10% owner | May 25, 2022 | Award | +15,389,995 | – | – | 16,973,020 |
| Frank D. Heuszel Chief Executive Officer, Director | May 4, 2022 | Award | +63,205 | $0.45 | $28.44K | 65,698 |
| Heng Fai Ambrose Chan Director, 10% owner | Apr 1, 2022 | Award | +894,084 | – | – | 1,583,025 |
| Heng Fai Ambrose Chan Director, 10% owner | Mar 9, 2022 | Buy | +3,986,877 | $0.38 | $1.52M | 26,178,632 |
| Heng Fai Ambrose Chan Director, 10% owner | Sep 8, 2021 | Buy | +12,155,591 | $1.23 | $14.95M | 22,191,755 |
| BioMedical Pte. Ltd. Global 10% owner | Jun 21, 2021 | Conversion | +1,120,170 | – | – | 10,036,164 |
| Heng Fai Ambrose Chan Director, 10% owner | Jun 16, 2021 | Buy | +555,000 | $1.70 | $943.50K | 8,947,012 |
| Heng Fai Ambrose Chan Director, 10% owner | Jun 15, 2021 | Buy | +115,960 | $1.77 | $205.25K | 7,507,972 |
| Heng Fai Ambrose Chan Director, 10% owner | Jun 15, 2021 | Buy | +884,040 | $1.69 | $1.49M | 8,392,012 |
| Heng Fai Ambrose Chan Director, 10% owner | May 26, 2021 | Conversion | +5,450,000 | – | – | 6,595,834 |
| BioMedical Pte. Ltd. Global 10% owner | Oct 16, 2020 | Conversion | +662,500 | – | – | 1,145,834 |
| Heng Fai Ambrose Chan Director, 10% owner | Aug 21, 2020 | Other | +483,334 | $6.48 | $3.13M | 483,334 |
| Heng Fai Ambrose Chan Director, 10% owner | Feb 24, 2020 | Award | +11,111,112 | $0.18 | $2.00M | 13,538,711 |
| Heng Fai Ambrose Chan Director, 10% owner | Feb 24, 2020 | Award | +11,111,111 | $0.18 | $2.00M | 13,538,710 |
| Heng Fai Ambrose Chan Director, 10% owner | Feb 18, 2020 | Award | +349,917 | – | – | 2,427,599 |
| Heng Fai Ambrose Chan Director, 10% owner | Nov 1, 2019 | Buy | +6,000,000 | $0.30 | $1.80M | 6,446,428 |
| Wah Wai Lo Director | Jul 23, 2019 | Award | +40,767 | – | – | 40,767 |
| John Thatch Director | Jul 23, 2019 | Award | +30,575 | – | – | 30,575 |
| Jason Grady Chief Operating Officer | Jul 23, 2019 | Award | +74,770 | – | – | 74,770 |
| Joseph L. Sanders Director | Jul 23, 2019 | Award | +30,575 | – | – | 684,970 |
| Stanley V. Grisham Director | Jul 23, 2019 | Award | +30,575 | – | – | 30,575 |
| Frank D. Heuszel Chief Executive Officer, Director | Jul 23, 2019 | Award | +74,770 | – | – | 74,770 |
| Heng Fai Ambrose Chan Director, 10% owner | Jul 23, 2019 | Award | +74,770 | – | – | 2,077,682 |
| Daniel DelGiorno Director | Jul 23, 2019 | Award | +40,767 | – | – | 40,767 |
| Pamela Avallone Director | Jul 23, 2019 | Award | +30,575 | – | – | 30,575 |
| Brett L. Scott Director | Jul 23, 2019 | Award | +30,575 | – | – | 30,575 |
| Heng Fai Ambrose Chan Director, 10% owner | Jun 10, 2019 | Buy | +2,000,000 | $0.50 | $1.00M | 2,002,912 |
| Joseph L. Sanders Director | Jun 6, 2019 | Buy | +1,181 | $0.48 | $567 | 654,395 |
| Joseph L. Sanders Director | May 20, 2019 | Buy | +3,181 | $1.05 | $3.34K | 653,214 |
| Heng Fai Ambrose Chan Director | Mar 25, 2019 | Conversion | +446,428 | $1.12 | $500.00K | 446,428 |
| Daniel DelGiorno Director | Mar 5, 2019 | Other | +130,435 | $1.15 | $150.00K | 130,435 |
| Heng Fai Ambrose Chan Director, 10% owner | Dec 17, 2018 | Buy | +612,245 | $0.98 | $600.00K | 1,786,531 |
| Heng Fai Ambrose Chan Director, 10% owner | Jul 3, 2018 | Buy | +214,286 | $1.40 | $300.00K | 1,174,286 |
| Joseph L. Sanders Director | Mar 30, 2018 | Buy | +400,000 | $0.75 | $300.00K | 650,033 |
| Jeffrey Ronaldi CEO, Director | Mar 21, 2018 | Award | +50,000 | – | – | 520,603 |
| Heng Fai Ambrose Chan Director, 10% owner | Dec 13, 2017 | Option exercise | +160,000 | $1.00 | $160.00K | 960,000 |
| Heng Fai Ambrose Chan Director, 10% owner | Dec 5, 2017 | Buy | +300 | $1.15 | $345 | 2,912 |
| Jeffrey Ronaldi CEO, Director | Nov 20, 2017 | Buy | +6,900 | $0.73 | $5.04K | 470,603 |
| Jeffrey Ronaldi CEO, Director | Nov 20, 2017 | Buy | +5,000 | $0.72 | $3.60K | 463,703 |
| Jeffrey Ronaldi CEO, Director | Nov 17, 2017 | Buy | +27,000 | $0.69 | $18.63K | 458,703 |
| Jeffrey Ronaldi CEO, Director | Nov 16, 2017 | Buy | +109,400 | $0.66 | $72.20K | 431,703 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
0.19%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-62.2%
From 0M shares
Short volume, 20 days
41.0%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of DSS's stock actually held short. Settlement fails (shares not delivered on time) peaked at 180,230 shares on Sep 4, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Dss Inc. Stockholder | Apr 29, 2026 | 31,939,778 | $23.06M | Apr 22, 2026 | 31,939,778 were issued to DSS by the issuing company in full and final satisfaction of the Second Amended Promissory Note. |
See a number that looks wrong?